Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2919
Selected: 0
NCT IDTitle
NCT03250273A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
NCT03949153Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis
NCT03199846Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT04655157Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
NCT00135356Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome
NCT06624475Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
NCT03342911Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
NCT03879811Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer
NCT03523572Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
NCT00282139Aripiprazole in the Treatment of Tourette's Syndrome
NCT03632187Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS
NCT03576963Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer
NCT00000963A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine
NCT00211263Bipolar Disorder Research Study for Ages 12 and Older
NCT03036098Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
NCT02713867A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks
NCT01290575Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes
NCT00035932Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV
NCT02297139Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib
NCT03566264Study of the Sudden Heart Failure Participant Population in the US
NCT04909801A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT05068609A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)
NCT00002246A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
NCT07602946SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma
NCT00464620Trial of Dasatinib in Advanced Sarcomas
NCT04674683Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
NCT01653470Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors
NCT05027061A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan
NCT04528680Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
NCT00245388Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia
NCT05148546Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer
NCT00168883Study for Patients With Non Small Cell Lung Cancer (NSCLC)
NCT05744466A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
NCT02982954A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer
NCT04671953Effect of BMS-986165 on the Blood Levels of Metformin
NCT00947245Japanese Bridging Study Conducted in the United States
NCT04065932A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets
NCT05044533A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF)
NCT01602822Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
NCT01594554A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.
NCT01086280Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic Treatments
NCT02626962Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma
NCT03281122A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection Fraction
NCT03165422A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
NCT02346942Factors Associated With Biologic DMARD Switching
NCT03123783CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab
NCT03487666OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
NCT00198302Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)
NCT06565975Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France
NCT02113657T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer